Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
23.03
-0.72 (-3.03%)
At close: Jun 23, 2026, 4:00 PM EDT
22.85
-0.18 (-0.78%)
After-hours: Jun 23, 2026, 7:42 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $338.04 million as of June 23, 2026. Its market cap has increased by 161.77% in one year.
Market Cap
338.04M
Enterprise Value
327.53M
1-Year Change
161.77%
Ranking
Category
Stock Price
$23.03
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $338.04M, an increase of 392.14%. That is a compound annual growth rate of 31.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 338.04M | 16.13% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 378.18M |
| Rocket Pharmaceuticals | 377.81M |
| Verastem | 373.46M |
| Vanda Pharmaceuticals | 360.81M |
| Silence Therapeutics | 355.67M |
| Atea Pharmaceuticals | 351.32M |
| Upstream Bio | 342.85M |
| OmniAb | 336.34M |